|
HY-P72411-100ug
|
MedChemexpress LLC
|
Siglec-10, Human (Biotinylated, HEK293, Fc-Avi)
|
|
|
|
|
HY-P72411-20ug
|
MedChemexpress LLC
|
Siglec-10, Human (Biotinylated, HEK293, Fc-Avi)
|
|
|
|
|
HY-P78206-20ug
|
MedChemexpress LLC
|
Siglec-10, Human (Biotinylated, R119A, HEK293, His-Avi)
|
|
|
|
|
HY-P78206-50ug
|
MedChemexpress LLC
|
Siglec-10, Human (Biotinylated, R119A, HEK293, His-Avi)
|
|
|
|
|
HY-P72476-10ug
|
MedChemexpress LLC
|
Siglec-10, Human (HEK293, Fc)
|
|
|
|
|
HY-P72476-5ug
|
MedChemexpress LLC
|
Siglec-10, Human (HEK293, Fc)
|
|
|
|
|
HY-P72476-50ug
|
MedChemexpress LLC
|
Siglec-10, Human (HEK293, Fc)
|
|
|
|
|
HY-P78514-20ug
|
MedChemexpress LLC
|
Siglec-10, Human (R119A, HEK293, His-Avi)
|
|
|
|
|
HY-P78514-50ug
|
MedChemexpress LLC
|
Siglec-10, Human (R119A, HEK293, His-Avi)
|
|
|
|
|
HY-W009732-1g
|
MedChemexpress LLC
|
Sinapinic acid [CAS 530-59-6]
|
|
Cancer-programmed cell death
|
|
|
HY-W009732-1mL
|
MedChemexpress LLC
|
Sinapinic acid [CAS 530-59-6] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-P1005-1mg
|
MedChemexpress LLC
|
Ac-DEVD-AFC [CAS 201608-14-2]
|
|
Cancer-programmed cell death
|
|
|
HY-P1005-10mg
|
MedChemexpress LLC
|
Ac-DEVD-AFC [CAS 201608-14-2]
|
|
Cancer-programmed cell death
|
|
|
HY-P1005-5mg
|
MedChemexpress LLC
|
Ac-DEVD-AFC [CAS 201608-14-2]
|
|
Cancer-programmed cell death
|
|
|
HY-101879-100mg
|
MedChemexpress LLC
|
Acridine Orange (hydrochloride) [CAS 65-61-2]
|
|
|
|
|
HY-101879-1mL
|
MedChemexpress LLC
|
Acridine Orange (hydrochloride) [CAS 65-61-2] (10mM in DMSO)
|
|
|
|
|
HY-N7476-10mg
|
MedChemexpress LLC
|
Colominic acid (sodium salt) [CAS 70431-34-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-N7476-5mg
|
MedChemexpress LLC
|
Colominic acid (sodium salt) [CAS 70431-34-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1221-100mg
|
MedChemexpress LLC
|
Flufenamic acid [CAS 530-78-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1221-1mL
|
MedChemexpress LLC
|
Flufenamic acid [CAS 530-78-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
